Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Viking Therapeutics just might be an attractive acquisition target for Pfizer.
Full Article
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Motley Fool
0 shares
1 views
You might like
Related news coverage
New Analysis Suggests Long-Term Effectiveness for Wegovy Users
Wibbitz Top Stories
New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .
NBC reports that patients taking
Novo Nordisk's..
Latest Weight-Loss Drug Faces Shortages
Wibbitz Top Stories